• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者中,SYNTAX 评分优于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。

Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

机构信息

Clinic for Cardiology, Clinical Center of Serbia, 26 Visegradska, 11000, Belgrade, Serbia.

出版信息

Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1. Epub 2013 Feb 27.

DOI:10.1007/s10554-013-0202-1
PMID:23443340
Abstract

This study evaluated additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). All six scores were calculated in 209 consecutive STEMI patients undergoing pPCI. Primary end-point was the major adverse cardiovascular event (MACE--composite of cardiovascular mortality, non-fatal myocardial infarction and stroke); secondary end point was cardiovascular mortality. Patients were stratified according to the SYNTAX score tertiles (≤12; between 12 and 19.5; >19.5). The median follow-up was 20 months. Rates of MACE and cardiovascular mortality were highest in the upper tertile of the SYNTAX score (p < 0.001 and p = 0.003, respectively). SYNTAX score was independent multivariable predictor of MACE and cardiovascular mortality when added to GRACE, TIMI, ZWOLLE, and PAMI risk scores. However, the SYNTAX score did not improve the Cox regression models of MACE and cardiovascular mortality when added to the CADILLAC score. The SYNTAX score has predictive value for MACE and cardiovascular mortality in patients with STEMI undergoing primary PCI. Furthermore, SYNTAX score improves prognostic performance of well-established GRACE, TIMI, ZWOLLE and PAMI clinical scores, but not the CADILLAC risk score. Therefore, long-term survival in patients after STEMI depends less on detailed angiographical characterization of coronary lesions, but more on clinical characteristics, myocardial function and basic angiographic findings as provided by the CADILLAC score.

摘要

本研究评估了 SYNTAX 评分在 ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(pPCI)时相对于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。在 209 例连续行 pPCI 的 STEMI 患者中计算了所有 6 种评分。主要终点是主要不良心血管事件(MACE——心血管死亡、非致死性心肌梗死和卒中的复合终点);次要终点是心血管死亡率。根据 SYNTAX 评分三分位数(≤12;12~19.5;>19.5)对患者进行分层。中位随访时间为 20 个月。SYNTAX 评分最高三分位组的 MACE 和心血管死亡率最高(p<0.001 和 p=0.003)。在加入 GRACE、TIMI、ZWOLLE 和 PAMI 风险评分后,SYNTAX 评分是 MACE 和心血管死亡率的独立多变量预测因子。然而,当 CADILLAC 评分加入时,SYNTAX 评分并未改善 MACE 和心血管死亡率的 Cox 回归模型。SYNTAX 评分对行直接 PCI 的 STEMI 患者的 MACE 和心血管死亡率具有预测价值。此外,SYNTAX 评分可改善 GRACE、TIMI、ZWOLLE 和 PAMI 等公认临床评分的预后性能,但不能改善 CADILLAC 风险评分。因此,STEMI 患者的长期生存较少取决于冠状动脉病变的详细血管造影特征,而更多地取决于 CADILLAC 评分提供的临床特征、心肌功能和基本血管造影发现。

相似文献

1
Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者中,SYNTAX 评分优于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。
Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1. Epub 2013 Feb 27.
2
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.应用 SYNTAX 评分预测行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者 1 年临床结局:STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评价单次大剂量替罗非班与阿昔单抗联合西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死研究)试验的一项亚研究。
JACC Cardiovasc Interv. 2011 Jan;4(1):66-75. doi: 10.1016/j.jcin.2010.09.017.
3
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].[改良CADILLAC、GRACE和TIMI风险评分对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后短期死亡风险的预测价值比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696.
4
Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.TIMI、PAMI、CADILLAC和GRACE风险评分对接受直接或补救性PCI的ST段抬高型急性冠状动脉综合征(STEACS)患者的预后预测价值比较。
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):227-33. doi: 10.1016/j.recesp.2011.10.019. Epub 2012 Jan 26.
5
SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.SYNTAX评分:急性ST段抬高型心肌梗死患者长期心脏死亡的独立预测因素。
Coron Artery Dis. 2012 Nov;23(7):445-9. doi: 10.1097/MCA.0b013e3283587835.
6
Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention.初始 SYNTAX 评分可预测经皮冠状动脉介入治疗后的主要不良心脏事件。
Angiology. 2014 May;65(5):408-12. doi: 10.1177/0003319713483542. Epub 2013 Apr 9.
7
GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction.在六个风险评分系统(CADILLAC、PAMI、TIMI、动态TIMI、兹沃勒)中,GRACE评分对ST段抬高型心肌梗死患者的长期死亡率预测显示出最佳预测价值。
PLoS One. 2015 Apr 20;10(4):e0123215. doi: 10.1371/journal.pone.0123215. eCollection 2015.
8
Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.SYNTAX评分II在预测接受直接经皮冠状动脉介入治疗患者1年预后中的应用价值
Coron Artery Dis. 2016 Sep;27(6):483-9. doi: 10.1097/MCA.0000000000000385.
9
Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.ST段抬高型心肌梗死多支血管病变患者基线SYNTAX评分与临床SYNTAX评分的长期预后价值比较
Coron Artery Dis. 2016 Jun;27(4):311-8. doi: 10.1097/MCA.0000000000000365.
10
Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.四种不同风险评分对接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者预后预测价值的比较。
Am J Cardiol. 2008 Jul 1;102(1):6-11. doi: 10.1016/j.amjcard.2008.02.088. Epub 2008 May 28.

引用本文的文献

1
Predictive Values of the CatLet© Angiographic Scoring System for 30-Day Cardiac Mortality in Patients after Primary Percutaneous Coronary Intervention.CatLet©血管造影评分系统对直接经皮冠状动脉介入治疗术后患者30天心脏死亡率的预测价值。
Rev Cardiovasc Med. 2025 Mar 17;26(3):28198. doi: 10.31083/RCM28198. eCollection 2025 Mar.
2
Application of thrombolysis in myocardial infarction risk index in the prediction of long-term outcomes for patients with ST-elevation myocardial infarction and multiple vessel disease: A single-center prospective observational cohort study.溶栓治疗在心肌梗死风险指数预测ST段抬高型心肌梗死合并多支血管病变患者长期预后中的应用:一项单中心前瞻性观察队列研究。
Exp Ther Med. 2021 Dec;22(6):1464. doi: 10.3892/etm.2021.10899. Epub 2021 Oct 20.
3

本文引用的文献

1
Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.SYNTAX 评分预测 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后无复流的价值。
Am J Cardiol. 2012 Mar 1;109(5):601-6. doi: 10.1016/j.amjcard.2011.10.013. Epub 2011 Dec 15.
2
The SYNTAX score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI.SYNTAX评分可预测接受直接经皮冠状动脉介入治疗的老年急性冠状动脉综合征患者的早期死亡风险。
J Invasive Cardiol. 2011 Dec;23(12):505-10.
3
SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements.
Prognosis evaluation of universal acute coronary syndrome: the interplay between SYNTAX score and ApoB/ApoA1.通用心血管综合征预后评估:SYNTAX 评分与载脂蛋白 B/载脂蛋白 A1 的相互作用。
BMC Cardiovasc Disord. 2020 Jun 15;20(1):293. doi: 10.1186/s12872-020-01562-6.
4
Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology.比较 TIMI、GRACE、PAMI 和 CADILLAC 风险评分在预测台湾 ST 段抬高型心肌梗死糖尿病患者长期心血管结局中的作用:来自台湾心脏病学会注册研究。
PLoS One. 2020 Feb 13;15(2):e0229186. doi: 10.1371/journal.pone.0229186. eCollection 2020.
5
ST-segment depression in left precordial leads in electrocardiogram of patients with acute inferior myocardial infarction undergoing primary percutaneous coronary intervention.接受直接经皮冠状动脉介入治疗的急性下壁心肌梗死患者心电图中左胸前导联ST段压低。
Interv Med Appl Sci. 2018 Dec;10(4):191-197. doi: 10.1556/1646.10.2018.19.
6
Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease.因多支血管和/或无保护左主干病变接受经皮冠状动脉介入治疗的稳定型心绞痛患者血清尿酸水平与SYNTAX评分II及长期死亡率的相关性
Int J Cardiovasc Imaging. 2019 Jan;35(1):1-7. doi: 10.1007/s10554-018-1446-6. Epub 2018 Aug 24.
7
Prognostic value of blood count parameters in patients with acute coronary syndrome.急性冠状动脉综合征患者血细胞计数参数的预后价值
Indian Heart J. 2018 Mar-Apr;70(2):233-240. doi: 10.1016/j.ihj.2017.06.017. Epub 2017 Jun 30.
8
ACTION (acute coronary treatment and intervention outcomes network) registry-GWTG (get with the guidelines) risk score predicts long-term mortality in acute myocardial infarction.ACTION(急性冠状动脉治疗与干预结果网络)注册研究-GWTG(遵循指南)风险评分可预测急性心肌梗死的长期死亡率。
Oncotarget. 2017 Oct 11;8(60):102559-102572. doi: 10.18632/oncotarget.21741. eCollection 2017 Nov 24.
9
Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.接受直接经皮冠状动脉介入治疗的所有ST段抬高型心肌梗死患者院内死亡的预后因素
Heart Asia. 2016 Jun 14;8(2):13-7. doi: 10.1136/heartasia-2015-010715. eCollection 2016.
10
The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention.ST段抬高型急性心肌梗死患者在直接冠状动脉介入治疗前,中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与心肌梗死溶栓风险评分之间的关系。
Postepy Kardiol Interwencyjnej. 2015;11(2):126-35. doi: 10.5114/pwki.2015.52286. Epub 2015 Jun 22.
介入心脏病学家、核心实验室技术人员和定量冠状动脉测量之间的 SYNTAX 评分再现性和可变性。
Circ Cardiovasc Interv. 2011 Dec 1;4(6):553-61. doi: 10.1161/CIRCINTERVENTIONS.111.961862. Epub 2011 Oct 25.
4
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.比较冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干和/或三血管病变:SYNTAX 试验 3 年随访结果。
Eur Heart J. 2011 Sep;32(17):2125-34. doi: 10.1093/eurheartj/ehr213. Epub 2011 Jun 22.
5
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.SYNTAX 评分在经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的预后价值:来自 ACUITY(急性血管造影和紧急介入治疗策略)试验的分析。
J Am Coll Cardiol. 2011 Jun 14;57(24):2389-97. doi: 10.1016/j.jacc.2011.02.032.
6
Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.SYNTAX 评分在接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者中的价值:MI SYNTAXscore 研究。
Am Heart J. 2011 Apr;161(4):771-81. doi: 10.1016/j.ahj.2011.01.004.
7
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.应用 SYNTAX 评分预测行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者 1 年临床结局:STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评价单次大剂量替罗非班与阿昔单抗联合西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死研究)试验的一项亚研究。
JACC Cardiovasc Interv. 2011 Jan;4(1):66-75. doi: 10.1016/j.jcin.2010.09.017.
8
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial.SYNTAX 评分在随机多中心 LEADERS(雷帕霉素洗脱可降解聚合物支架与依维莫司洗脱金属支架)试验所有入组患者人群中的风险评估价值。
J Am Coll Cardiol. 2010 Jul 20;56(4):272-7. doi: 10.1016/j.jacc.2010.03.044.
9
Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.左主干支架置入术后的长期临床结果:来自 RESEARCH(雷帕霉素洗脱支架在鹿特丹心脏病学医院评估)和 T-SEARCH(紫杉醇支架在鹿特丹心脏病学医院评估)注册研究的结果。
JACC Cardiovasc Interv. 2010 Jun;3(6):584-94. doi: 10.1016/j.jcin.2010.03.017.
10
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.5 年临床结果的动脉再血管化治疗研究 II(ARTS II)的西罗莫司洗脱支架治疗多支血管原发冠状动脉病变的患者。
J Am Coll Cardiol. 2010 Mar 16;55(11):1093-101. doi: 10.1016/j.jacc.2009.11.049. Epub 2010 Feb 18.